The UK's National Institute of Health and Clinical Excellence has published new guidance for the month of May.
The published guidance includes Clinical Guidelines that cover Lipid Modification and an update to the Type 2 Diabetes Guideline.
The former guideline (Quick Reference PDF) provides advice for risk management by lipid modification in patients at high risk of cardiovascular disease and those who have already had a cardiovascular event or have cardiovascular disease. This guideline has been reported in the general media (BBC) due to the prediction that an additional 1.5 million people could be prescribed a statin.
The update to the Diabetes guideline (Quick Reference PDF) covers:
Lifestyle Management
Appropriate use of self monitoring of blood glucose
Medication
Blood pressure targets and management
CVD Risk prediction
Lipid targets and management
Antithrombotics
Eye, Kidney and Nerve Damage
Simvastatin 40mg is the recommended first line therapy for all patients. There is no recommended target for primary prevention and moving high intensity statins is not recommended as routine.
Hat tip: Matt
No comments:
Post a Comment